» Articles » PMID: 33120952

Distinct Osteogenic Potentials of BMP-2 and FGF-2 in Extramedullary and Medullary Microenvironments

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Oct 30
PMID 33120952
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2) have been regarded as the major cytokines promoting bone formation, however, several studies have reported unexpected results with failure of bone formation or bone resorption of these growth factors. In this study, BMP-2 and FGF-2 adsorbed into atellocollagen sponges were transplanted into bone defects in the bone marrow-scarce calvaria (extramedullary environment) and bone marrow-abundant femur (medullary environment) for analysis of their in vivo effects not only on osteoblasts, osteoclasts but also on bone marrow cells. The results showed that BMP-2 induced high bone formation in the bone marrow-scarce calvaria, but induced bone resorption in the bone marrow-abundant femurs. On the other hand, FGF-2 showed opposite effects compared to those of BMP-2. Analysis of cellular dynamics revealed numerous osteoblasts and osteoclasts present in the newly-formed bone induced by BMP-2 in calvaria, but none were seen in either control or FGF-2-transplanted groups. On the other hand, in the femur, numerous osteoclasts were observed in the vicinity of the BMP-2 pellet, while a great number of osteoblasts were seen near the FGF-2 pellets or in the control group. Of note, FCM analysis showed that both BMP-2 and FGF-2 administrated in the femur did not significantly affect the hematopoietic cell population, indicating a relatively safe application of the two growth factors. Together, these results indicate that BMP-2 could be suitable for application in extramedullary bone regeneration, whereas FGF-2 could be suitable for application in medullary bone regeneration.

Citing Articles

The potential link between the development of Alzheimer's disease and osteoporosis.

Nasme F, Behera J, Tyagi P, Debnath N, Falcone J, Tyagi N Biogerontology. 2025; 26(1):43.

PMID: 39832071 DOI: 10.1007/s10522-024-10181-z.


Delivery of a Jagged1-PEG-MAL hydrogel with pediatric human bone cells regenerates critically sized craniofacial bone defects.

Kamalakar A, Tobin B, Kaimari S, Robinson M, Toma A, Cha T Elife. 2024; 13.

PMID: 39401071 PMC: 11473100. DOI: 10.7554/eLife.92925.


Multi-organ developmental toxicity and its characteristics in fetal mice induced by dexamethasone at different doses, stages, and courses during pregnancy.

Zhao X, Xiao H, Li X, Zhu L, Peng Y, Chen H Arch Toxicol. 2024; 98(6):1891-1908.

PMID: 38522057 DOI: 10.1007/s00204-024-03707-4.


Bioinformatics Analysis and Experimental Validation of Differential Genes and Pathways in Bone Nonunions.

Xiong W, Shu X, Huang L, He S, Liu L, Li S Biochem Genet. 2024; 62(6):4494-4517.

PMID: 38324134 DOI: 10.1007/s10528-023-10633-0.


Delivery of A Jagged1-PEG-MAL hydrogel with Pediatric Human Bone Cells Regenerates Critically-Sized Craniofacial Bone Defects.

Kamalakar A, Tobin B, Kaimari S, Robinson M, Toma A, Cha T bioRxiv. 2023; .

PMID: 37873448 PMC: 10592619. DOI: 10.1101/2023.10.06.561291.


References
1.
Globus R, Patterson-Buckendahl P, GOSPODAROWICZ D . Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology. 1988; 123(1):98-105. DOI: 10.1210/endo-123-1-98. View

2.
Kikuta J, Wada Y, Kowada T, Wang Z, Sun-Wada G, Nishiyama I . Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest. 2013; 123(2):866-73. PMC: 3561830. DOI: 10.1172/JCI65054. View

3.
Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P . Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res. 2002; 17(10):1859-71. DOI: 10.1359/jbmr.2002.17.10.1859. View

4.
Komori T, Ono M, Hara E, Ueda J, Nguyen H, Nguyen H . Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. Sci Rep. 2018; 8(1):2612. PMC: 5805778. DOI: 10.1038/s41598-018-21000-0. View

5.
Urist M, Sato K, Brownell A, Malinin T, LIETZE A, Huo Y . Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med. 1983; 173(2):194-9. DOI: 10.3181/00379727-173-41630. View